| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
94,670,000 |
| Market
Cap: |
78.41(M) |
| Last
Volume: |
940,193 |
Avg
Vol: |
712,579 |
| 52
Week Range: |
$0.754 - $7.66 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Assertio Therapeutics is a pharmaceutical company. Co.'s primary marketed products include: INDOCIN® (indomethacin) Suppositories and INDOCIN® (indomethacin) Oral Suspension, which is a suppository form and oral solution of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis; CAMBIA® (diclofenac potassium for oral solution), which is a prescription NSAID indicated for the acute treatment of migraine attacks in adults; and Otrexup® (methotrexate) injection, used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dawes Karen A |
Director |
– • – |
2020-05-08 |
4 |
AS |
$0.79 |
$12,531 |
D/D |
(15,834) |
84,589 |
|
-12% |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2020-04-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,433) |
62,916 |
|
- |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2020-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,370 |
70,349 |
|
- |
|
| Galeota James Jr |
Director |
– • – |
2020-03-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,492 |
12,492 |
|
- |
|
| Mason Heather L |
Director |
– • – |
2020-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,394 |
14,394 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2020-02-12 |
4 |
D |
$1.35 |
$12,886 |
D/D |
(9,545) |
103,208 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,588 |
112,753 |
|
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2020-02-12 |
4 |
D |
$1.35 |
$41,861 |
D/D |
(31,008) |
244,739 |
|
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
97,412 |
275,747 |
|
- |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2020-02-12 |
4 |
D |
$1.35 |
$12,886 |
D/D |
(9,545) |
44,979 |
|
- |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,588 |
54,524 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2020-02-06 |
4 |
D |
$1.04 |
$2,411 |
D/D |
(2,318) |
85,165 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2020-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,700 |
87,483 |
|
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2020-02-06 |
4 |
D |
$1.04 |
$22,454 |
D/D |
(21,590) |
178,335 |
|
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2020-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,399 |
199,925 |
|
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2019-12-01 |
4 |
D |
$0.76 |
$7,762 |
D/D |
(10,213) |
137,526 |
|
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2019-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,860 |
147,739 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-12-01 |
4 |
D |
$0.76 |
$1,861 |
D/D |
(2,449) |
80,783 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,359 |
83,232 |
|
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2019-11-12 |
4 |
B |
$0.73 |
$18,250 |
D/D |
25,000 |
112,879 |
2.81 |
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-11-11 |
4 |
B |
$0.73 |
$7,259 |
D/D |
10,000 |
74,873 |
2.74 |
- |
|
| Staple Peter D |
Director |
– • – |
2019-11-11 |
4 |
B |
$0.71 |
$9,911 |
I/I |
13,900 |
13,900 |
2.1 |
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-09-18 |
4 |
D |
$1.33 |
$4,529 |
D/D |
(3,405) |
64,873 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,623 |
68,278 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-08-20 |
4 |
B |
$1.45 |
$21,000 |
D/D |
14,000 |
56,655 |
2.74 |
- |
|
165 Records found
|
|
Page 1 of 7 |
|
|
0.04 (5.49%) 
